Ligand Pharmaceuticals, Inc. (LGND)
202.91
-8.57
(-4.05%)
USD |
NASDAQ |
Mar 13, 16:00
202.73
-0.18
(-0.09%)
After-Hours: 20:00
Ligand Pharmaceuticals Shareholders Equity (Quarterly) : 1.017B for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Amicus Therapeutics, Inc. | 274.24M |
| ADMA Biologics, Inc. | 477.32M |
| Merck & Co., Inc. | 52.61B |
| Globus Medical, Inc. | 4.573B |
| Establishment Labs Holdings, Inc. | 23.55M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.561B |
| Total Liabilities (Quarterly) | 543.42M |
| Debt to Equity Ratio | 0.4439 |
| Current Ratio | 22.23 |
| Net Debt Paydown Yield | -2.38% |